Document Classification

Section Type: RESULTS

Text: A significant difference (P < 0. 001 by analysis of variance) between the E2 1-mg/NGM 90-microg and NETA regimens was seen for HDL-C and HDL2-C concentrations, which were elevated in subjects receiving E2 1 mg/NGM 90 microg but reduced (-9. 1 % [-11. 1 %, -7. 1 %] and -12. 3 % [-14. 3 %, -10. 3 %] for HDL-C at months 7 and 12, respectively ; -14. 2 % [-18. 0 %, -10. 4 %] and -2. 5 % [-7. 8 %, +2. 8 %] for HDL2-C at months 7 and 12, respectively) in those receiving E2/NETA.